Data is not available at this time.
Cross Country Healthcare, Inc. operates as a leading workforce solutions and staffing firm specializing in healthcare. The company provides flexible staffing solutions, including travel nursing, per diem staffing, and permanent placement services, catering to hospitals, clinics, and other healthcare facilities. Its revenue model is driven by contract labor placements, where it earns fees based on the duration and skill level of the healthcare professionals it supplies. The healthcare staffing industry is highly competitive and cyclical, influenced by labor shortages, regulatory changes, and healthcare demand fluctuations. Cross Country differentiates itself through its national scale, deep industry relationships, and technology-driven recruitment platforms. The company holds a strong position in the travel nursing segment, which remains a critical revenue driver amid persistent nurse shortages. Its ability to quickly adapt to market needs and maintain a robust candidate pipeline supports its competitive edge.
Cross Country Healthcare reported revenue of $1.34 billion for FY 2024, reflecting its scale in the healthcare staffing sector. However, the company posted a net loss of $14.6 million, with diluted EPS of -$0.44, indicating margin pressures. Operating cash flow stood at $120.1 million, demonstrating solid cash generation despite profitability challenges. Capital expenditures were modest at $8.7 million, suggesting disciplined investment in growth.
The company’s negative net income highlights earnings volatility, likely tied to labor cost inflation or contract pricing dynamics. Operating cash flow remains healthy, supporting liquidity. With minimal debt ($3.9 million) and $81.6 million in cash, Cross Country maintains a strong liquidity position, allowing flexibility to navigate cyclical demand shifts.
Cross Country’s balance sheet is robust, with cash and equivalents of $81.6 million and negligible debt, yielding a net cash position. This conservative leverage profile provides resilience against industry downturns. The absence of dividends suggests a focus on reinvestment or strategic flexibility.
Revenue trends reflect demand for healthcare staffing, though profitability remains inconsistent. The company does not pay dividends, prioritizing operational reinvestment or potential M&A. Growth hinges on addressing labor shortages and expanding service offerings in high-demand specialties.
The market likely prices Cross Country based on cyclical recovery potential in healthcare staffing. Negative earnings may weigh on valuation multiples, but strong cash flow and a clean balance sheet could support investor confidence in long-term positioning.
Cross Country’s national footprint and technology-driven recruitment provide scalability. Persistent healthcare labor shortages underpin demand, but profitability improvement depends on cost management and pricing power. The outlook remains cautiously optimistic, contingent on industry dynamics and execution.
Company filings (10-K), financial statements
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |